tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

GeneDx price target raised to $125 from $100 at BTIG

BTIG analyst Mark Massaro raised the firm’s price target on GeneDx (WGS) to $125 from $100 and keeps a Buy rating on the shares. The company reported a strong bounce-back in Q2, driving a big $17M beat on the top line, along with a strong gross margin beat, and there is more runway ahead, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1